Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis

NCT03174587 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

BIOLOGICAL: allogenic bone marrow derived mesenchymal stem cells

Sponsor

Corestemchemon, Inc.

Collaborators

[object Object]